
    
      A single center, open-label, multiple-dose study design will be used. Planned enrollment is
      20 subjects to complete 15. Subjects must have a clinical diagnosis of onychomycosis of each
      great toenail and a clinical diagnosis of onychomycosis of six of the remaining toenails.
    
  